DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lisofylline
Lisofylline
Compositions for the Reduction of Scarring
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Harnessing the Power of P450 Enzymes Aaron T. Larsen
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Pentoxifylline As an Adjuvant Treatment in Renal Cell Carcinoma
In T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7
Lista De Productos En Orden Alfabético
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
31St International Symposium on Intensive Care and Emergency Medicine
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
(12) United States Patent (10) Patent No.: US 9,181.233 B2 Heiser Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
WO 2018/005695 Al O
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Ep 1919867 B1
(12) United States Patent (10) Patent No.: US 8,343,962 B2 Kisak Et Al
Pharmaabkommen A1 E
Top View
Customs Tariff - Schedule Xxi - 1
The Anti-Inflammatory Compound Lisofylline Prevents Type I Diabetes in Non-Obese Diabetic Mice
Wo 2007/044693 A2
Ep 2325169 A9
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Harmonized Tariff Schedule of the United States (2006) (Rev
WO 2013/106547 Al 18 July 2013 (18.07.2013) P O P C T
Compound Name Matrix Methodology
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
Pentoxifylline and Its Active Metabolite Lisofylline Attenuate Transforming
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Comparative Assessment of the New PDE7 Inhibitor – GRMS-55 and Lisofylline in Animal Models of Immune-Related Disorders: a PK/PD Modeling Approach
Role of Phosphodiesterase in the Biology and Pathology of Diabetes
PK/PD Studies on Non-Selective PDE Inhibitors in Rats Using Camp As a Marker of Pharmacological Response
Contact Information
Schedule Clxxiii - European Union
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
WO 2007/016766 Al
In Vitro Evaluation of Antioxidant Activity of Novel Theophylline Derivatives
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016